BioCentury
ARTICLE | Financial News

Avenue Therapeutics financial update

January 4, 2016 8:00 AM UTC

Avenue Therapeutics Inc., New York, N.Y. Business: Neurology Date announced: 2015-12-30 Note: Avenue Therapeutics, a majority-owned subsidiary of Fortress Biotech Inc. (NASDAQ:FBIO, New York, N.Y.), ...